DiaMedica Therapeutics Stock Forward View - Price Action Indicator
| DMAC Stock | USD 8.18 0.14 1.74% |
DiaMedica Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast DiaMedica Therapeutics stock prices and determine the direction of DiaMedica Therapeutics's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of DiaMedica Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, The RSI of DiaMedica Therapeutics' share price is at 51 suggesting that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling DiaMedica Therapeutics, making its price go up or down. Momentum 51
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.17) | EPS Estimate Current Year (0.72) | EPS Estimate Next Year (0.76) | Wall Street Target Price 15.5 | EPS Estimate Current Quarter (0.16) |
Using DiaMedica Therapeutics hype-based prediction, you can estimate the value of DiaMedica Therapeutics from the perspective of DiaMedica Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards DiaMedica Therapeutics using DiaMedica Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards DiaMedica using crowd psychology based on the activity and movement of DiaMedica Therapeutics' stock price.
DiaMedica Therapeutics Implied Volatility | 1.37 |
DiaMedica Therapeutics' implied volatility exposes the market's sentiment of DiaMedica Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if DiaMedica Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that DiaMedica Therapeutics stock will not fluctuate a lot when DiaMedica Therapeutics' options are near their expiration.
DiaMedica Therapeutics after-hype prediction price | USD 8.05 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
DiaMedica | Build AI portfolio with DiaMedica Stock |
Prediction based on Rule 16 of the current DiaMedica contract
Based on the Rule 16, the options market is currently suggesting that DiaMedica Therapeutics will have an average daily up or down price movement of about 0.0856% per day over the life of the 2026-04-17 option contract. With DiaMedica Therapeutics trading at USD 8.18, that is roughly USD 0.007004 . If you think that the market is fully incorporating DiaMedica Therapeutics' daily price movement you should consider acquiring DiaMedica Therapeutics options at the current volatility level of 1.37%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 DiaMedica Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast DiaMedica Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in DiaMedica Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for DiaMedica Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current DiaMedica Therapeutics' open interest, investors have to compare it to DiaMedica Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of DiaMedica Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in DiaMedica. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
DiaMedica Therapeutics Additional Predictive Modules
Most predictive techniques to examine DiaMedica price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for DiaMedica using various technical indicators. When you analyze DiaMedica charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| 0.085 | 0.085 |
| Check DiaMedica Therapeutics Volatility | Backtest DiaMedica Therapeutics | Information Ratio |
DiaMedica Therapeutics Trading Date Momentum
| On February 02 2026 DiaMedica Therapeutics was traded for 8.18 at the closing time. The top price for the day was 8.38 and the lowest listed price was 7.95 . The trading volume for the day was 128.3 K. The trading history from February 2, 2026 did not affect price variability. The overall trading delta against the current closing price is 1.71% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare DiaMedica Therapeutics to competition |
Other Forecasting Options for DiaMedica Therapeutics
For every potential investor in DiaMedica, whether a beginner or expert, DiaMedica Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. DiaMedica Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in DiaMedica. Basic forecasting techniques help filter out the noise by identifying DiaMedica Therapeutics' price trends.DiaMedica Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with DiaMedica Therapeutics stock to make a market-neutral strategy. Peer analysis of DiaMedica Therapeutics could also be used in its relative valuation, which is a method of valuing DiaMedica Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
DiaMedica Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how DiaMedica Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading DiaMedica Therapeutics shares will generate the highest return on investment. By undertsting and applying DiaMedica Therapeutics stock market strength indicators, traders can identify DiaMedica Therapeutics entry and exit signals to maximize returns.
DiaMedica Therapeutics Risk Indicators
The analysis of DiaMedica Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in DiaMedica Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting diamedica stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.39 | |||
| Semi Deviation | 4.31 | |||
| Standard Deviation | 4.66 | |||
| Variance | 21.68 | |||
| Downside Variance | 20.11 | |||
| Semi Variance | 18.58 | |||
| Expected Short fall | (3.83) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for DiaMedica Therapeutics
The number of cover stories for DiaMedica Therapeutics depends on current market conditions and DiaMedica Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that DiaMedica Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about DiaMedica Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
DiaMedica Therapeutics Short Properties
DiaMedica Therapeutics' future price predictability will typically decrease when DiaMedica Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of DiaMedica Therapeutics often depends not only on the future outlook of the potential DiaMedica Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. DiaMedica Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 40.4 M | |
| Cash And Short Term Investments | 44.1 M |
Check out Historical Fundamental Analysis of DiaMedica Therapeutics to cross-verify your projections. For information on how to trade DiaMedica Stock refer to our How to Trade DiaMedica Stock guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Will Biotechnology sector continue expanding? Could DiaMedica diversify its offerings? Factors like these will boost the valuation of DiaMedica Therapeutics. Projected growth potential of DiaMedica fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every DiaMedica Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of DiaMedica Therapeutics is measured differently than its book value, which is the value of DiaMedica that is recorded on the company's balance sheet. Investors also form their own opinion of DiaMedica Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is DiaMedica Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because DiaMedica Therapeutics' market value can be influenced by many factors that don't directly affect DiaMedica Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between DiaMedica Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DiaMedica Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, DiaMedica Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.